Peg3 encodes a C2H2 type zinc finger protein that is implicated in a novel physiological pathway regulating core body temperature, feeding behavior, and obesity in mice. Peg3 +/− mutant mice develop an excess of abdominal, subcutaneous, and intra-scapular fat, despite a lifetime of lower food intake than wild-type animals. However, they start life with reduced fat reserves and are slower to enter puberty. These mice maintain a lower core body temperature, fail to respond to a cold challenge, and have lower metabolic activity as measured by oxygen consumption. Plasma leptin levels are significantly higher than in wild types, and Peg3 +/− mice appear to have developed leptin resistance. Administration of exogenous leptin resulted in a significant reduction in food intake in wild-type mice that was not observed in Peg3 +/− mutants. This mutation, which is strongly expressed in hypothalamic tissue during development, has the capacity to regulate multiple events relating to energy homeostasis.
Accumulating evidence suggests that imprinted genes are important in the regulation of postweaning development and metabolism. In humans, several metabolic disorders show a parent-oforigin specific inheritance pattern, including transient neonatal diabetes mellitus that is associated with the inheritance of a paternal duplication of chromosome 6q24 (5) . Recent work with transgenic mice has revealed that this disorder may be caused by the overexpression of the paternally expressed zinc finger protein gene ZAC1 (6) . Infants inheriting a maternal duplication of chromosome 15q11-q13 develop Prader-Willi syndrome characterized by chronic hyperphagia and obesity (7) . In sheep, the callipyge mutation causes a dysregulation of several imprinted genes in the Dlk1/Gtl2 cluster, which is also conserved in humans and mice (8, 9) . When this mutation is paternally inherited, there is an overexpression of Dlk1 and Peg11 resulting in muscle hypertrophy associated with decreased adiposity in those muscles (10) . The paternally expressed Dlk1 inhibits the differentiation of preadipocytes into adipocytes in adipose tissue (11) , and congruent with this, increased adiposity is observed in Dlk1 knockout mice (12) . Interestingly, mice with mutations in another cluster of imprinted genes, the GNAS locus, also show parent-of-origin specific metabolic phenotypic changes. Mice inheriting deletions of maternal Gnas are obese and hypometabolic, whereas those with disruption of the paternal allele are thin and hypermetabolic (13) . Moreover, mice with a mutation of the paternally expressed transcript Gnasxl have a number of metabolic phenotypic changes, suggesting that this imprinted gene coordinates a number of physiological adaptations to energy regulation including suckling, blood glucose homeostasis, and lipogenesis (14) . Finally, the maternally expressed Grb10 gene located on mouse chromosome 11 has been shown to regulate prenatal growth and adult metabolism (15, 16) . Mice carrying a deletion in this gene have overgrowth of both the embryo and placenta, but as adults they have increased lean mass, decreased fat mass, and faster glucose clearance.
Peg3 (paternally expressed gene 3, also known as Pw1) is located on mouse proximal chromosome 7, a region syntenic with human chromosome 19q13.4 (17) , which appears to have tumor suppressor properties in adults (18) . The Peg3 gene is highly conserved between mice and humans, suggesting a key role for the gene throughout evolution (17) . The imprinting status of Peg3 is identical in both mice and humans, though multiple isoforms have been identified in humans, whereas only one isoform is known in mice (19, 20) . The Peg3 protein has 12 Kruppel type zinc finger domains and two proline-rich periodic repeat domains, with the major targets of expression being the placenta, gonads, hypothalamus, and adult skeletal muscle (21, 22) . Strong adult expression is also observed in 2-month-olds with RT-PCR in white adipose tissue, with relatively weak expression observed in brown adipose tissue (unpublished observations, N. Miyoshi). Prenatally (day 12.5), expression of the protein is observed in the diencephalon, somites, gut, hypothalamus, pituitary gland, tongue, and vertebral cartiliage; expression status in brown adipose tissue is currently unknown (23) . At the cellular level, Peg3 has been shown to be critical to several apoptopic pathways. It appears to be especially important in p53-mediated apoptosis, cooperating with Siah1a in the translocation of Bax proteins from cytosol to mitochondria in fibroblasts (24) (25) (26) and in neurons being up-regulated in vivo and in vitro after hypoxia (27) . Peg3 protein also interacts with the RING finger domains of Siah1, Siah2, and Traf2 forming multiprotein complexes during development, which are thought to be important modulators in the TNF signaling pathway, which blocks apoptosis (23, 26) . Hence, the Peg3 protein, via regulation of apoptotic pathways, has the capacity to shape and remodel the development of those structures in which it is expressed.
The aim of the present study was to investigate the role of the Peg3 gene on post-weaning growth and development in the adult mouse. Two recent studies have implicated Peg3 in the control of adult body composition. In the pig, Peg3 was identified from a whole genome scan as a candidate gene for the regulation of intramuscular fat content (28) , whereas both Peg3 and the paternally expressed Mest/Peg1 genes have been shown to have altered expression in a high-fat diet induced mouse model of obesity (29) . In the course of our studies of Peg3 +/− mutants, we observed that they were hypophagic but had elevated fat levels, a finding that merited further metabolic studies.
MATERIALS AND METHODS

Subject animals, housing, and care
All subjects were laboratory mice (Mus musculus), and all procedures were undertaken with the relevant ethical approvals. The original Peg3 mutation was developed on the 129Sv inbred strain, and the generation of the targeted mutation is described elsewhere (30) . Briefly, a 4.8 kb IRESβgeo-SV40 polyadenylation selection cassette was inserted into the 5′ coding exon of the Peg3 gene in embryonic stem cells of the 129Sv inbred strain, using gene targeting. Heterozygous embryos inheriting the Peg3 βgeo mutation from the paternal germ line showed no detectable wildtype Peg3 mRNA but did show appropriate β-galactosidase (β-Gal) expression. Both heterozygous and homozygous subjects showed identical β-Gal expression, demonstrating the functional equivalence between heterozygotes and homozygotes. Animals were housed at the Sub-Department of Animal Behavior (Madingley, Cambridge) on a reverse 12-12 dark-light cycle, under a constant temperature of 21°C and 55% humidity to facilitate observational studies. All animals were given ad libitum access to water and the RM3(E) chow diet supplied by Lillico. All procedures were performed under appropriate Home Office licenses.
Statistical analysis
Parametric tests were used when assumptions of these tests were met, with t tests being undertaken unless otherwise stated. The hypothalamic neuropeptide data were analyzed using GLM tests. If these assumptions were not met, suitable transformations of the data were performed. If the assumptions of parametric tests were still not met, nonparametric tests were performed. All statistics were undertaken using Minitab13.1 and SPSS11.5. Data are means ± SE.
Body composition analysis
The body weight, abdominal, subcutaneous, and intra-scapular fat and the gastrocnemius muscle of each subject animal were removed immediately after culling. Abdominal fat was taken from the intra-abdominal area surrounding the lower intestines, testes, ovaries, and bladder. In addition, abdominal fat was also removed from a fat pad under each kidney. Subcutaneous fat was located under the skin around the tail, flank regions, hips, and inguinal and pectoral regions. Intra-scapular fat was removed from the intra-scapular region. Gastrocnemius muscle was taken from one lower limb per animal.
Food intake measurements
Six-month-old adult wild-type and Peg3 +/− males and females were singly housed. The body weight and food present in a sealed food hopper were recorded weekly for 16 wk, 1 h after the start of the dark phase using an electronic balance.
Puberty
One female from separate litters containing five to seven pups was removed from its mother at day 28 pn and placed individually into small cages. From day 30 pn, a vaginal smear was taken daily and the body weight of females was recorded using an electronic balance. The vaginal smear was taken by swabbing the inside of the vagina with a small, damp cotton bud and smearing the contents onto a clean glass slide. Smearing occurred daily until the first oestrus smear was observed under a microscope as determined by the presence of cornified epithelial cells and an absence of leucocytes.
Metabolic activity
Oxygen consumption was measured by indirect calorimetry using an Oxymax 4.4 System (Columbus Instruments, Columbus, OH). Experiments were performed on groups of four animals (2 wild types, 2 mutants; 1 mouse per chamber) with water but not food available ad libitum. After a 2 h settling period, air samples were collected every 4 min (room air reference every 16 min, with the air flow set at 500 ml/min) over a 2 h period.
Running wheel activity
Four-to six-month-old wild-type and Peg3 +/− males were placed into a large cage (dimensions) with free access to water and food. At one end of the cage, subject animals had access to a running wheel (dimensions) connected to an electronic counter, which measures both forward and reverse revolutions made. Subjects were placed in the apparatus at the start of the dark phase, and the total number of revolutions made after 12 h (end of dark phase) and 24 h (end of light phase) was recorded. Subjects were tested over three separate periods (not on consecutive days) on the apparatus, with the results from the second and third trials being averaged.
Body temperature
The rectal temperature of adult 3-to 6-month-old wild-type and Peg3 +/− males and females was recorded using a miniature electronic rectal thermometer (Vet tech solutions ltd). Temperatures were taken 1 h after the start of the dark phase, once weekly for 17 wk.
Cold challenge
Six-month-old wild-type and Peg3 +/− mice had their rectal temperatures measured. They were then immediately placed in a refrigerator at 4°C. At 10 min intervals, for a total of 30 min, each mouse was removed individually and its temperature recorded. After 30 min, the mice were removed and left to stand at room temperature 21°C for 10 min before rectal temperature was measured.
Norepinephrine challenge
Six-month-old wild-type and Peg3 +/− mice had their rectal temperature measured at room temperature (21°C). Each mouse was given 1 mg/kg norepinephrine intraperitoneally. Rectal temperature was then recorded after 10, 20, 30, and 60 min.
Serum hormone analysis
Animals were culled at 23-wk-old, and trunk blood was collected. Plasma was separated by centrifugation, aliquoted, and stored at -80°C until required for assay. Glucose was measured using INFINITY™ glucose reagent (Sigma Diagnostics, St. Louis, MO). Insulin leptin and corticosterone were assayed using commercially available ELISA kits (Crystal Chem, Inc., Chicago, IL; ImmunChem TM Double Antibody; ICN Biomedicals). Plasma free fatty acid (FFA) was measured using enzymatic methods (NEFAC, Wako, Neuss, Germany). Serum insulin-like growth factor I (IGF-I) levels were measured by double-antibody, IGF binding protein-blocked RIA (31) . T3 and T4 were assayed using Amerlex-Mab kits (Kodak Clinial Diagnostics LTD, Amersham, UK).
Leptin challenge
The food intake and body weight of 6-month-old wild-type and Peg3 +/− males were recorded 1 h after the start of the dark phase for 5 consecutive days, giving the daily food intake for 4 consecutive days (control). At the same time on the 5th day and following 3 days, 125 µl of leptin was administered subcutaneously to each subject animal. The body weight and food intake of subject animals were measured for these 4 days (leptin treatment) and a final set of 4 days when no leptin was administered (post-leptin treatment).
In situ hybridization
In situ hybridization was performed on 10 µM frozen brain sections from 23-wk-old and 40-dayold mice and analyzed from film as described previously (32) . Antisense oligonucleotide probes designed for neuropeptide Y (NPY), proopiomelanocortin (POMC), melanin-concentrating hormone (MCH), and orexin mRNA were used. Analysis of NPY, POMC, MCH, and orexin mRNA was carried out on six sections of the arcuate and ventomedial and dorsomedial nuclei of the hypothalamus using NIH image software. An integrated optical density was calculated for each animal and standaridsed by comparison with radioactive standards (C 14 microscales, range 30-862 mCi/g; Amersham). The optical densities were measured in six consecutive sections, and the average value for each animal was used to calculate group means. The duration of exposure to the x-ray film varied according to the mRNA transcript under investigation. For quantification of NPY, POMC, MCH, and orexin mRNA, sections were placed in x-ray cassettes and then exposed to autoradiographic film for 5-7 days.
RESULTS
Body weight
Both male and female Peg3 +/− mice are growth retarded at birth compared with wild-type mice, having a significantly lower mean pup weight (1.20±0.02 g cf 1.40±0.03 g, t=5.56, df=49, P<0.001). This growth deficiency continues through lactation and during adulthood, with mutant mice of all ages and both sexes being smaller than wild-type animals.
Body fat
Male subjects for this study were all sexually mature with a mean age of 11 ± 1 months for both wild- 
Gastrocnemius muscle
Mutant Peg3
+/− males had significantly smaller gastrocnemius muscles than wild-type males (Fig.  1B) , both in absolute terms (0.11±0.00 g cf 0.15±0.01 g, t=7.05, df=116, P<0.001) and as a percentage of body weight (0.38±0.01% cf 0.44±0.02%, t=3.23, df=116, P=0.002). In addition, adult mutant females (n=20) had significantly less gastrocnemius muscle (0.08±0.00 g cf 0.11±0.00 g, Mann-Whitney, W=21.0, P=0.005) than wild-type females (n=7).
Food intake
Adult mutant males did not consume as much food as wild-type males (Fig. 1C , mean weekly intake: 29.8±0.8 g cf 36.8±0.6 g, t=6.82, df=14, P<0.001), and had a significantly slower increase in body weight (Fig. 1D) . Mutant Peg3 +/− females also ate less than wild-type females (26.9±0.5 g cf 32.6±0.8 g, t=5.95, df=11, P<0.001).
Puberty
Peg3
+/− females entered puberty significantly later than wild-type females (60±2 days cf 42±2 days) (33). The earliest age at which wild-type females enter puberty was observed to be day 35 pn. At this age, mutant Peg3 +/− females had significantly less white fat than wild-type females (0.08±0.01 g cf 0.22±0.01 g, t=9.92, df=24, P<0.001), even relative to body weight (0.62±0.05% cf 1.35±0.09%, Mann-Whitney, W=245.0, P<0.001). However, at day 60 pn (the mean age of onset of first oestrus in mutant females), Peg3 +/− females had significantly more white fat relative to body weight than wild-type females (2.37±0.23% cf 1.51±0.11%, t=3.37, df=21,P=0.003). At the same age (day 35 pn), there were no significant differences in the levels of white fat between wild-type and mutant males (Fig. 1E , GLM with genotype as a fixed factor and litter size as a covariate, F 1,22 =1.741, P=0.201). However, wild-type males (n=15) have higher levels of intrascapular fat compared with Peg3 +/− mutant males (n=10) at this age (Fig. 1F, GLM, F 1,22 =10 .812, P=0.003).
Metabolic data
Mutants had a significantly lower oxygen consumption than wild-type males (0.97±0.05 ml/kg/min VO 2 cf 1.41±0.06 ml/kg/min VO 2 , one-way ANOVA, F 1,11 =32.09, P<0.001), even when body weight was accounted for (42.4±2.7 ml/kg/min VO 2 /weight cf 52.2±1.2 ml/kg/min VO 2 /weight, one-way ANOVA, F 1,11 =12.28, P=0.005).
Running wheel activity
No difference between wild-type and Peg3 +/− males was recorded in wheel running activity (revolutions per 24 h) (wt, n=20, median 1422; Peg3 +/− , n=21, median = 824; Mann-Whitney, W=473, P=0.284). However, wild-type males performed a lower proportion of their wheel running during the dark phase than did Peg3 +/− males (80% cf. 90%, Mann-Whitney, W=304, P=0.021).
Body temperature
Mutant Peg3
+/− males had a significantly lower resting body temperature than wild-type males over the 16 wk they were measured ( Fig. 2A , RMA with week as a within subject factor and genotype as a between subject factor-effect of genotype: F 1,14 =15.40, P=0.002). The same trend was also observed in females, as adult mutant Peg3 +/− females had a lower mean resting body temperature than wild-type females (RMA, F 1,13 =6.58, P=0.025). Adult mutant Peg3 +/− males were unable to increase their body temperature when confronted with a cold challenge, which wild types were able to do (Fig. 2B , RMA with time as a within subject factor and genotype as a between subject factor, time × genotype: F 4,40 =11.392, P<0.001). However, peripheral norepinephrine challenge produced similar increases in body temperature in both wild-type and mutant males (Fig. 2C , RMA, time × genotype: F 4,40 =0.818, P=0.521).
Serum analysis
The composition of adult wild-type and Peg3 +/− male serum was analyzed to determine if the body fat phenotype was related to any gross differences in hormones or metabolites. No significant differences in levels of insulin, glucose, corticosterone, FFA, IGF-I, T3, or T4 were observed between adult genotypes (Table 1) . However, consistent with the higher levels of body fat, Peg3 +/− males had significantly higher levels of leptin hormone than wild-type males (Table  1 , Mann-Whitney, W=36.0, P=0.004).
Leptin administration and food intake
Congruent with these elevated leptin levels, Peg3 +/− males were found to be less responsive to exogenous leptin than controls. Both Peg3 +/− and wild-type males significantly decreased their food intake levels during leptin administration but wild type did so by significantly more than mutants (Fig. 3A, one-way ANOVA, F 1,18 =32.62, P<0.001) . After the termination of leptin treatment, both groups of males significantly increased their percentage of food intake, but wildtype males increased their intake by significantly more than did mutant Peg3 +/− males (one-way ANOVA, F 1,18 =7.74, P=0.013). Significant differences in body weight changes were also observed (Fig. 3B) . Both wild-type and mutant males lost weight in response to leptin treatment and gained weight after the termination of leptin treatment (RMA, effect of treatment: F 2,36 =57.23, P<0.001), though this effect was significantly greater in wild types (RMA, genotype × treatment: F 2,36 =3.51,P=0.040).
Hypothalamic neuropeptides
In the arcuate nucleus of the hypothalamus, pre-pubertal mutant Peg3 +/− neurons expressed significantly less POMC mRNA (Fig. 4A, F 1 (Fig. 4D, F 1,8 =29 .27, P<0.001) than wild-type males.
In adult animals, there was no significant difference in the levels of expression of POMC mRNA in the arcuate nucleus between mutant and wild-type males (Fig. 4A, F 1,8 =3.32, P=0.111) . However, adult mutants did express significantly more POMC mRNA than pre-pubertal mutants (F 1,9 =26.489, P<0.001), while there was no difference in the expression of POMC mRNA between adult and pre-pubertal wild types (F 1,7 =0.004, P<0.954). Furthermore, mutant Peg3 +/− arcuate neurons actually expressed significantly less NPY mRNA than adult wild-type males (Fig. 4B, F 1,8 =15 .03, P<0.006) and pre-pubertal mutant neurons (F 1,9 =106.214, P<0.001). No difference was found between adult and pre-pubertal wild-type males in the expression of NPY mRNA (F 1,7 =1.126, P<0.330).
In the lateral hypothalamus, adult Peg3
+/− neurons expressed significantly more MCH than wildtype adults (Fig. 4C, F 1,8 =13 .97, P<0.007) but significantly less MCH than neurons in prepubertal mutant mice (F 1,9 =31,067, P<0.001). There was no difference in the expression of MCH between pre-pubertal and adult wild-type mice (F 1,7 =2.496, P<0.167). No differences were also found in the expression of orexin mRNA between adult wild-type and Peg3 +/− males (Fig. 4D,  F 1,8 =0 .097, P=0.764) or pre-pubertal wild-type males (F 1,7 =0.679, P<0.441). However, adult Peg3 +/− males expressed significantly less orexin mRNA in the lateral hypothalamus than prepubertal mutant males (F 1,9 =28.654, P<0.001).
DISCUSSION
Post-pubertal male and female Peg3 +/− mutants have higher levels of abdominal, subcutaneous and intra-scapular fat than wild-type animals, even though they have a smaller body weight throughout life (Fig. 1A and D) . This increase in adiposity is not restricted to an increase in any one fat tissue type but was found in all three regions investigated. Interestingly, the increase in intra-scapular fat in mutant animals histologically appeared to be white fat specific as brown fat was considerably reduced. This phenotype is even more striking given that pre-pubertal (day 35 pn) mutant Peg3 +/− females and males actually have less white and intra-scapular fat than wild types, respectively. In addition to the elevated body fat in adults, it was also found that Peg3 +/− mutants had smaller gastrocnemius muscles than wild-type animals (Fig. 1B) .
The lack of Peg3 expression in fetal and extra-embryonic tissues leads to growth retardation during embryogenesis in mutant animals (30, 33) . Postnatally they continue to be growth retarded and are impaired in suckling, receiving fewer resources during the lactational period than wild-type animals (33) . Weaning is delayed in mutants, and they enter puberty later. Postpubertally, mutant Peg3 +/− males and females intake fewer calories eating 80% of the food consumed by wild-type animals (Fig. 1C) .
Despite experiencing significantly less energy intake during embryogenesis via the placenta, and in adulthood by ingestion, post-pubertal mutants have elevated levels of total body fat; we, therefore, investigated energy expenditure. Although Peg3 +/− animals do not show any significant difference in their levels of running activity, they do have metabolic dysfunctions. They have a lower core body temperature than wild-type animals ( Fig. 2A) and a lower metabolic rate as shown by reduced oxygen consumption. In addition, the smaller size of gastrocnemius skeletal muscle in mutants compared with controls (Fig. 1B) suggests that Peg3 +/− animals are less able to increase their body temperature through shivering thermogenesis, while reduced brown fat may contribute to deficits in nonshivering thermogenesis. Body temperature is regulated by the medial preoptic area (MPOA) of the hypothalamus promoting heat gain and inhibiting heat loss through activation of brown adipose tissue thermogenesis. Norepinephrine release from the sympathetic nervous system operates via β-adrenergic receptors and cyclic AMP to initiate adaptive thermogenesis and an increase in metabolic rate and oxygen consumption. Previous work established that there is a delay in the development of this system as Peg3 pups are unable to thermoregulate for themselves at day 12 pn compared with wild types (33) . We also found that mutant Peg3 +/− males are unable to increase their body temperature when presented with a 30 min cold challenge (Fig. 2B) but are able to increase their body temperature when administered norepinephrine (Fig. 2C) . Peg3 +/− animals are therefore able to respond to sympathetic norepinephrine challenge, albeit at a lower level, but there exists a deficit in activating this system via the hypothalamus.
Adult Peg3
+/− males have substantially elevated levels of circulating leptin, which is consistent with their increased adiposity ( Table 1) . Leptin is secreted from adipocytes and circulates in the blood stream before acting on leptin receptors in the arcuate nucleus of the hypothalamus. This leads to a cascade of activity within the hypothalamus that eventually triggers an increase or decrease in energy intake and expenditure in proportion to the amount of circulating leptin. Like many physiological homeostatic systems, this pathway operates accurately within limits, but in obese individuals the excessive amounts of circulating leptin down-regulates the pathway leading to leptin-resistance and the loss of energy balance. Peg3 +/− males appear to be leptin resistant, as they do not change food intake and body weight to the same degree as control animals in response to the administration and withdrawal of exogenous leptin (Fig. 3A and B) . Leptin also plays a key role in the regulation of reproduction (34) , and the significantly higher levels of white fat required by mutant Peg3 +/− females to enter puberty compared with wild-type females are also likely to represent a leptin-mediated hypothalamic dysfunction.
The leptin-regulated melanocortin pathway provides a homeostatic regulatory system from adipocytes to the brain, involving neurotransmitters and hormones that regulate energy balance and particularly food intake (35, 36) . There are two major sets of neurons that express leptin receptors within the arcuate nucleus; one that increases food intake through the release of orexigenic neuropeptides such as NPY and agouti related protein (AGRP), and another that decreases food intake through the release of anorexigenic neuropeptides such as cocaine and amphetamine related transcript (CART) and α melanocortin stimulating hormone (α-MSH). In addition, AGRP and α-MSH are both antagonistic ligands for the anorexigenic melanocortin-4-receptor (MC4R) located in the lateral hypothalamus and within the arcuate nucleus itself. Although this pathway is hugely important, other neurotransmitters also play a role in the regulation of energy balance. Within the lateral hypothalamus the expression of the orexigenic neuropeptides orexin-A, orexin-B, and MCH increases feeding and decreases metabolic rate (35, 37) .
The majority of reports of increased adiposity in rodents relate the pathology to a disruption in one or more of these homeostatic mechanisms (38) . Being born underweight and having lower levels of white fat, the pre-pubertal mutant Peg3 +/− hypothalamus expresses NPY, MCH, and orexin mRNA at significantly higher levels and POMC mRNA at significantly lower levels than wild-type individuals to increase their energy intake ( Fig. 4A-D) . Although there are limitations in extrapolating in situ measured mRNA transcript levels to protein levels, it appears as if there is a dysfunction of metabolic regulation in the hypothalamus. Despite an overexpression of orexigenic and under-expression of anorexigenic neuropeptides, mutant Peg3 +/− animals fail to respond appropriately to these signals by increasing their energy intake.
From a mechanistic viewpoint, it is not yet clear how the Peg3 gene is involved in energy balance regulation. Unlike other mouse models of obesity, the dysfunction in the Peg3 mutant does not involve a specific receptor or just one of the many peptides involved in food-intake regulation (35, 36, 38, 39) . Rather, it appears to be regulating developmental processes that predispose the brain to a lower set-point in energy balance. Understanding how such a mechanism coordinates the many components of energy homeostasis makes this mutant unique for the study of increased adiposity and the changing set-point with respect to lifetime fat deposition. The likeliest explanation is that the mutation in the Peg3 gene disrupts normal hypothalamic development leading to a cascade of energy balance dysfunctions. The hypothalamus has long been known to be critical for energy homeostasis through its actions on food intake, body temperature, metabolic rate, and physical activity (35) . Peg3 is expressed at high levels throughout the embryonic, pre-pubescent, and adult brain in several of these brain areas (30) . The expression is particularly high in the arcuate, ventromedial, dorsomedial, paraventricular (PVN), supra-optic (SON), and supra-chiasmatic nuclei of the hypothalamus, MPOA, BNST, and amygdala. Through its role in various apoptotic pathways, the Peg3 gene has the capacity to regulate normal development in these brain areas (23) (24) (25) (26) (27) . This has already been demonstrated in Peg3 +/− mutant females in a previous study where a deficit in maternal behavior was associated with a decrease of neurons expressing the neuropeptide oxytocin in the MPOA, SON, and PVN of the hypothalamus post-partum (30) .
A further consideration is the effects on energy balance regulation that may indirectly result from the action of the Peg3 gene in the placenta. There is increasing evidence that events before birth can have a strong causal effect on metabolic phenotypes, and numerous studies demonstrate that intrauterine growth retardation is a high risk factor for developing obesity later in life (40) . The so-called "thrifty phenotype" or "fetal origins" hypothesis argues that adaptations are made by a developing organism in response to a poor in utero environment, leading to an increased risk of adiposity and other diseases in adulthood (40, 41) . A variation of the thrifty phenotype hypothesis is that it is not low birth weight per se that leads to the increased risk of adult obesity but rather that a common factor influences both intrauterine growth and later life events such as the energy homeostasis (42, 43) . For example, there is good evidence that individual genes (e.g., the glucose sensor enzyme glucokinase) can regulate both prenatal growth and insulin homeostasis (44) . It is also important to note that four imprinted genes; the paternally expressed Peg3, Pref1/Dlk1 (12) , and Gnasxl (14) and the maternally expressed Grb10, also have significant roles in both embryonic development and postnatal energy regulation (12, (14) (15) (16) . Moreover, the expression of Peg3 and other imprinted genes could be altered not only by genetic, but also by epigenetic factors, with environmental factors as subtle as maternal nutrition potentially deregulating this expression during neonatal development (45) .
Finally, an important implication of this work and other studies is the question of why parent-oforigin specific gene silencing has come to regulate metabolic phenotypes. The expression of imprinted genes in the hypothalamus, placenta, and embryo implicates them in resource allocation, but until recently empirical data for this involvement were generally limited to early development. During embryogenesis and lactation, the majority of imprinted genes regulate growth in a predictable manner, with paternally and maternally expressed genes being growth enhancing and suppressing respectively (46) . Recent data for the post-weaning period is more confusing with no overall clear correlation between parent-of-origin expression and phenotype. For instance, mice with targeted mutations of the paternally expressed genes, Peg3 and Dlk1 have increased adiposity, but mice carrying a paternal deletion of the GNAS cluster are lean. There are not yet enough data to clarify the role of maternally expressed genes in metabolic phenotypes. Why this form of gene silencing should have evolved to regulate multiple aspects of energy regulation currently remains unclear; however, it is evident that this is a research area of growing importance with a number of imprinted genes being identified as having conserved metabolic functions across several species [e.g., sheep (10), pigs (28), mice, humans]. In particular, Peg3 appears to have remarkably conserved monoallelic expression across diverse taxa and developmental stages, suggesting that this gene may have played a critical role in regulating resource allocation during mammalian evolution (19, 47, 48) . Data are means ± SE; n = 8 for wild-type and n = 5 for Peg3 +/-males. ***P < 0.05. +/− (n=8) adult females. B) the response to a cold challenge in wild-type and Peg3 +/− adult males (n=6 per group). Rectal temperature is recorded at room temperature (R0), after 10, 20, and 30 min at 4°C (C10, C20, C30), and then after a further 10 min at room temperature (R10). C) Response to a noradrenaline challenge in wild-type and Peg3 +/− adult males (n=6 per group). ***P < 0.005; *P < 0.05. +/− adult males during (leptin) and after (post-leptin) daily administration of 125ul of leptin (n=10 per group). B) the change in body weight over 4 day periods by wild-type and Peg3 +/− adult males before (control), during (leptin) and after (post-leptin) daily administration of 125 ul of leptin (n=10 per group). ***P < 0.005; *P < 0.05. +/− males have significantly more POMC mRNA than pre-pubertal mutant Peg3 +/− males. B) NPY mRNA in the arcuate nucleus is significantly higher in pre-pubertal mutant Peg3 +/− males than wild-type males. Adult mutant Peg3 +/− males have significantly less NPY mRNA than pre-pubertal mutant Peg3 +/− males and wild-type males. C) MCH mRNA in the lateral hypothalamus is significantly higher in both pre-pubertal and adult mutant Peg3 +/− males than wild-type males. Adult mutant Peg3 +/− males have significantly less MCH mRNA than prepubertal mutant Peg3 +/− males. D) Orexin mRNA in the lateral hypothalamus is significantly lower in adult mutant Peg3 +/− males than pre-pubescent mutant Peg3 +/− males. **P < 0.01; *P < 0.05; ###P<0.005.
